Teva Settles Nexium Pay-for-Delay Suit for $24 Million

Drug Industry Daily
A A
Israeli drugmaker Teva will pay $24 million to settle a pay-for-delay lawsuit over its generic version of AstraZeneca’s heartburn relief drug Nexium.

To View This Article:

Login

Subscribe To Drug Industry Daily